<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03289312</url>
  </required_header>
  <id_info>
    <org_study_id>2017ZDSYSLLoss</org_study_id>
    <nct_id>NCT03289312</nct_id>
  </id_info>
  <brief_title>Dissecting How Peripheral Lymphocytes Are Lost During Sepsis</brief_title>
  <acronym>SLL</acronym>
  <official_title>Dissecting How Peripheral Lymphocytes Are Lost During Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southeast University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is an observational, clinical study. We recruit sepsis patients to investigate what
      drives peripheral lymphocyte loss in sepsis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is an observational, clinical study. We recruit patients with diagnosis of new onset
      sepsis within 24h, collect and record clinical characteristics：

      ①Demography data，diagnosis, admission source, infection source, APACHE II,SOFA
      scores;②Endotoxin levels and PaO2 measured;③Immune and systemic inflammatory indicators：T,
      RR, WBC, ALC, etc.;④Complicated organs dysfunctions: duration and therapy;⑤Incidence of
      ICU-acquired infection and prognosis.The blood samples were collected for
      apoptosis,necrosis,autophagy,pyroptosis measurements.The aim of this study is to investigate
      how peripheal lymphocyte loss relates to outcome and the mechanisms of peripheal lymphocyte
      loss in different condition.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 11, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>lymphocyte loss</measure>
    <time_frame>day of inclussion and 7th day after inclussion</time_frame>
    <description>ratios of T cells loss by different mechanism in different subgroups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>prognosis</measure>
    <time_frame>28-day after inclussion</time_frame>
    <description>28-day prognosis:survive or not</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complicated organ dysfunction</measure>
    <time_frame>during 28 days after inclussion</time_frame>
    <description>duration and surpport therapy</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Sepsis</arm_group_label>
    <description>Diagnosis of new onset sepsis within 24h without history of tumor, hematological or immunological disease, and treatment with chemotherapy agents or corticosteroids within 6 months prior to or during the hospitalization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health control</arm_group_label>
    <description>Health vonlunteers</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of new onset sepsis within 24h.

        Exclusion Criteria:

          -  History of tumor, hematological or immunological disease, and treatment with
             chemotherapy agents or corticosteroids within 6 months prior to or during the
             hospitalization.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Health volunteers

        Exclusion Criteria:

          -  History of tumor, hematological or immunological disease, and treatment with
             chemotherapy agents or corticosteroids within 6 months prior to or during the
             hospitalization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ming Xue, MD</last_name>
    <phone>08615195971003</phone>
    <email>xueming0304@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongda Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2017</study_first_submitted>
  <study_first_submitted_qc>September 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2017</study_first_posted>
  <last_update_submitted>December 26, 2017</last_update_submitted>
  <last_update_submitted_qc>December 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Jianfeng Xie</investigator_full_name>
    <investigator_title>Southeast University, China</investigator_title>
  </responsible_party>
  <keyword>sepsis, lymphocyte</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

